Practice toolkit
Sexual Health Patient Screening Toolkit: Candidacy & Intake Protocol
After utilizing this toolkit, clinical teams will be able to standardize patient intake, identify qualified candidates for sexual wellness protocols, and mitigate clinical risk.
This practical toolkit provides clinical and operational guidelines for screening male and female sexual wellness patients in a specialty or regenerative medicine practice. It establishes baseline evaluation parameters, standardized clinical metrics, and explicit candidacy exclusions. Practices can immediately implement these workflows to streamline intake while maintaining rigorous clinical standards.
The checklist
- Establish a private, compliant clinical intake environment for sensitive patient discussions.
- Select and integrate validated survey tools (IIEF-5/SHIM for male, FSFI for female).
- Formulate standard baseline laboratory panels (hormone, metabolic, vascular markers).
- Define explicit clinical inclusion criteria based on dysfunction severity and etiology.
- Document absolute contraindications, including active malignancy and uncontrolled bleeding disorders.
- Establish a physician review step prior to clearing candidates for procedures or therapies.
- Draft a comprehensive informed consent form detailing realistic treatment timelines and goals.
- Implement pre-procedure baseline photographic or clinical documentation protocols where appropriate.
- Train front-desk and clinical staff on professional terminology and intake workflows.
- Schedule standardized follow-up evaluations at set intervals using baseline questionnaires.
Clinical Rationale and Intake Structure
Establishing a standardized screening framework for sexual wellness therapies ensures patient safety, aligns expectations, and optimizes clinical outcomes. Practices integrating shockwave, biologic, or peptide protocols must differentiate functional vasculogenic or hormonal etiologies from underlying psychological or severe anatomical pathologies.
A structured intake combines confidential patient-reported questionnaires with targeted clinical evaluations. Staff should be trained on privacy protocols and comfortable conducting discussions around sensitive symptoms to ensure accurate baseline reporting. Learn more about operational support for physician practices.
Validated Diagnostic Tools for Baseline Evaluation
Objective screening requires validated survey instruments to quantify dysfunction severity and establish a baseline prior to initiating therapy. For male sexual health, the International Index of Erectile Function (IIEF-5) or the Sexual Health Inventory for Men (SHIM), paired with the Erection Hardness Score (EHS), provides standardized numerical baseline data.
For female sexual health, the Female Sexual Function Index (FSFI) evaluates desire, arousal, lubrication, orgasm, satisfaction, and pain across distinct subscales. Administering these tools during initial intake and at scheduled follow-up intervals creates verifiable clinical documentation to track treatment progress.
Candidacy Criteria Across Treatment Modalities
Ideal candidates for regenerative sexual wellness modalities typically present with mild-to-moderate vasculogenic erectile dysfunction or mild-to-moderate female sexual interest/arousal disorder. Patients evaluating low-intensity shockwave or non-invasive mechanical therapies must have intact tissue response mechanisms and adequate vascular supply.
When considering biologics or energy-based devices, clinicians must evaluate local tissue integrity, hormone balance, and systemic microvascular health. Optimal outcomes correlate directly with precise patient selection rather than broad-spectrum application.
Absolute and Relative Contraindications
To preserve clinical safety, practices must enforce clear exclusion criteria. Absolute contraindications include active pelvic or genital malignancy, uncontrolled bleeding disorders, active local infection, or unmanaged systemic endocrine conditions that impede healing.
Relative contraindications require careful medical oversight and may include severe neurological deficits, unmanaged metabolic syndrome, heavy tobacco use, or severe pelvic anatomical distortion (such as advanced Peyronie's disease without specialist co-management). Clinical decision-making remains strictly with the treating physician.
Consent, Expectation Setting, and Documentation
Informed consent protocols should explicitly outline the mechanisms, expected course of treatment, and realistic goals of intervention. Patients must understand that regenerative sexual wellness procedures support tissue function and remodeling, rather than serving as immediate symptomatic fixes.
Documenting baseline laboratory panels (including total/free testosterone, estradiol, SHBG, HbA1c, and lipid profiles) provides essential context. Clear communication regarding multi-session protocols and lifestyle modifications helps align patient expectations with physiologic realities.
Questions practices ask
- Why are validated questionnaires like IIEF-5 and FSFI necessary for practice integration?
- Validated questionnaires provide standardized, quantifiable baseline metrics that allow clinicians to objectively assess dysfunction severity. They also serve as clear benchmarks to evaluate progress across treatment protocols and protect clinical compliance through objective documentation.
- How should practices handle patients presenting with severe, long-standing dysfunction?
- Patients with end-stage organic vascular disease or severe neurological damage may have reduced responsiveness to biological or acoustic therapies. Clinicians should conduct thorough vascular and metabolic workups, set conservative expectations, and consider multi-modality or specialist-led management strategies.
- Which initial laboratory tests should be included in a sexual wellness screening panel?
- Recommended baseline panels typically include total and free testosterone, estradiol, sex hormone-binding globulin (SHBG), thyroid profile, lipid panel, and HbA1c. These laboratory markers help identify underlying metabolic or endocrine factors that could impair therapeutic outcomes.
- What role do non-physician staff play in the screening workflow?
- Non-physician staff can facilitate the collection of intake forms, administer validated questionnaires, and ensure pre-treatment lab orders are complete. However, final candidate clearance, diagnostic interpretation, and treatment plan authorization must be performed by the licensed treating physician.
Contact Dallas Regenerative Solutions to request a clinical consultation and learn how to integrate standardized regenerative service lines into your practice. Request a consultation or browse more practice toolkits.
Talk to a regenerative supply specialist
Tell us the service line you are building and we will map the biologics, devices, and supplies that fit your protocol and margins.
- Licensed Texas distributor since 2016
- Protocol, training, and workflow support
- Straight answers on cost per treatment
Most practices hear back the same business day.
Bring regenerative medicine into your practice.
Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.